The Irish government is developing a policy aimed at increasing the use of biosimilars and helping the industry to expand domestically, using experiences in other countries as a guide, with a view to improving access to cheaper biologic medicines.
Speaking at the BioPharma Ambition conference in Dublin on Sept
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?